Finance

Lists
SLVNF:OTCMKTS
Solvonis Therapeutics PLC
0,0020 USD
-58,33%
(-0,0028) 1D
28-авг., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLVNF...
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
7,86 млн
Avg. vol.
69,75 миң
Volume
30,83 миң
52-wk high
0,01 USD
52-wk low
0,00 USD
Shares outstanding
6,81 млд
No. of employees
6
Open
0,00 USD
High
0,00 USD
Low
0,00 USD
Mkt. cap
7,86 млн
Avg. vol.
69,75 миң
Volume
30,83 миң
52-wk high
0,01 USD
52-wk low
0,00 USD
Shares outstanding
6,81 млд
No. of employees
6
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
808,50 миң
808,50 миң
699,50 миң
699,50 миң
Operating expense
808,50 миң
808,50 миң
979,00 миң
979,00 миң
Total operating expenses
808,50 миң
808,50 миң
979,00 миң
979,00 миң
Operating income
-808,50 миң
-808,50 миң
-979,00 миң
-979,00 миң
Other non operating income
-
-
-
-
EBT including unusual items
-810,50 миң
-810,50 миң
-2,06 млн
-2,06 млн
EBT excluding unusual items
-810,50 миң
-810,50 миң
-928,00 миң
-928,00 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-810,50 миң
-810,50 миң
-2,06 млн
-2,06 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
2,00 миң
2,00 миң
Interest expense
-2,00 миң
-2,00 миң
-
-
Net interest expenses
-2,00 миң
-2,00 миң
2,00 миң
2,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google колдонмолору